Drug tolerance in Mycobacterium tuberculosis (Q33977977)

30 July 2017

title

Drug tolerance in Mycobacterium tuberculosis (English)

1 reference

Mycobacterium tuberculosis

30 July 2017

main subject

0 references

author

Reynaldo Dietze

1 reference

ORCID Public Data File 2021

author name string

R S Wallis

1

1 reference

30 July 2017

S Patil

2

1 reference

30 July 2017

S H Cheon

3

1 reference

30 July 2017

K Edmonds

4

1 reference

30 July 2017

M Phillips

5

1 reference

30 July 2017

M D Perkins

6

1 reference

30 July 2017

M Joloba

7

1 reference

30 July 2017

A Namale

8

1 reference

30 July 2017

J L Johnson

9

1 reference

30 July 2017

L Teixeira

10

1 reference

30 July 2017

R Dietze

11

1 reference

30 July 2017

S Siddiqi

12

1 reference

30 July 2017

R D Mugerwa

13

1 reference

30 July 2017

K Eisenach

14

1 reference

30 July 2017

J J Ellner

15

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

30 July 2017

number of pages

7

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

30 July 2017

volume

43

1 reference

30 July 2017

issue

11

1 reference

30 July 2017

page(s)

2600-2606

1 reference

Induction of the antigen 85 complex of Mycobacterium tuberculosis in sputum: a determinant of outcome in pulmonary tuberculosis treatment

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89531

Time to Detection of Mycobacterium Tuberculosis in Sputum Culture Correlates With Outcome in Patients Receiving Treatment for Pulmonary Tuberculosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89531

Short-course chemoprophylaxis for tuberculosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89531

Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89531

Biogenesis of the mycobacterial cell wall and the site of action of ethambutol

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89531

Quantitative culture of Mycobacterium tuberculosis from clinical sputum specimens and dilution endpoint of its detection by the Amplicor PCR assay

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89531

Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89531

The action of antituberculosis drugs in short-course chemotherapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89531

Phenotypic tolerance: the search for beta-lactam antibiotics that kill nongrowing bacteria

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89531

Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89531

Five year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in south India.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89531

Bacteriostatic and bactericidal activity of antituberculosis drugs against Mycobacterium tuberculosis, Mycobacterium avium-Mycobacterium intracellulare complex and Mycobacterium kansasii in different growth phases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89531

Short term chemotherapy of tuberculosis. Factors affecting relapse following short term chemotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89531

A Controlled Trial of 3-Month, 4-Month, and 6-Month Regimens of Chemotherapy for Sputum-smear-negative Pulmonary Tuberculosis: Results at 5 Years

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89531

From the Centers for Disease Control and Prevention. Use of short-course tuberculosis preventive therapy regimens in HIV-seronegative persons

29 October 2018

1 reference

12 December 2020

A controlled trial of 2-month, 3-month, and 12-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 60 months

1 reference

12 December 2020

Significance of in-vitro penicillin tolerance in experimental enterococcal endocarditis

1 reference

12 December 2020

Importance of rifampicin in combined daily/intermittent chemotherapy for tuberculosis

1 reference

12 December 2020

Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations

1 reference

12 December 2020

Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months

1 reference

12 December 2020

Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis

1 reference

12 December 2020

Rifampin preventive therapy for tuberculosis infection: experience with 157 adolescents

1 reference

12 December 2020

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

1 reference

12 December 2020

Shortest possible acceptable effective chemotherapy in ambulatory patients with pulmonary tuberculosis. Part II. Results during the 24 months after the end of chemotherapy

1 reference

12 December 2020

Identifiers

PMC publication ID

89531

1 reference

30 July 2017

1 reference